Vyepti الاتحاد الأوروبي - البولندية - EMA (European Medicines Agency)

vyepti

h. lundbeck a/s - eptinezumab - choroby migreny - Środki przeciwbólowe - vyepti is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.